Avidity Biosciences Total Non-Operating Income/Expense 2019-2024 | RNA

Avidity Biosciences total non-operating income/expense for the twelve months ending September 30, 2024 was $0.044B, a 122.88% increase year-over-year.

  • Avidity Biosciences annual total non-operating income/expense for 2023 was $0.023B, a 375.36% increase from 2022.
  • Avidity Biosciences annual total non-operating income/expense for 2022 was $0.005B, a 11609.52% increase from 2021.
  • Avidity Biosciences annual total non-operating income/expense for 2021 was $0B, a 153.85% decline from 2020.

Avidity Biosciences Total Non-Operating Income/Expense 2019-2024 | RNA

  • Avidity Biosciences annual total non-operating income/expense for 2023 was $0.023B, a 375.36% increase from 2022.
  • Avidity Biosciences annual total non-operating income/expense for 2022 was $0.005B, a 11609.52% increase from 2021.
  • Avidity Biosciences annual total non-operating income/expense for 2021 was $0B, a 153.85% decline from 2020.